Pearsanta

Pearsanta, Inc., established in January 2023 as a wholly-owned subsidiary of Aditxt, is a company that delivers "digital health" to healthcare institutions and patients through personalized, data-driven diagnostic and monitoring solutions. Pearsanta is addressing the growing demand for convenient, rapid, personalized, and high-quality laboratory testing anytime and anywhere. The company integrates the collection, processing, monitoring, and reporting of biological samples to provide actionable information to end users. This will require the integration of multiple components, including collection devices, point-of-care (POC) "lab-on-a-chip" technology, laboratory-developed tests (LDT) assays, data-driven analytical engines, and telemedicine.